XTEP Projects Over 10% Net Profit Growth for 2025 Driven by Product Strength and Enhanced Running Shoe Portfolio

Deep News
03/26

On March 26, XTEP International announced its 2025 full-year results, reporting a 4.2% increase in revenue to RMB 14.151 billion and a 10.8% rise in net profit to RMB 1.372 billion. The group's net cash position also saw significant growth, surging 73.4% to RMB 1.707 billion. Over the past year, XTEP has continued to refine its product portfolio, strengthening its leading position in the running category through high-quality offerings. In August 2025, the company launched the new-generation championship running shoe series, "160X 7." Equipped with cutting-edge technology and advanced carbon plates, the series has set new performance benchmarks for professional running shoes, consistently helping elite athletes achieve outstanding results in domestic and international competitions. Other models in the championship series, such as the "260X" and "360X," have also gained popularity among runners, becoming preferred choices for improving speed training and daily running experiences. To cater to the diverse needs of runners, XTEP introduced the "Qing Yun" flagship cushioning running shoe series, offering a comprehensive range from non-carbon plate to built-in carbon plate designs, ensuring enhanced comfort and ergonomic benefits for everyday runners. Additionally, XTEP has been actively expanding its mass-market product lineup. During the period, its flagship product, the "Two Thousand Kilometers" series, gained attention among casual runners due to its advanced cushioning technology and highly durable outsoles. The series performed strongly in online channels, with annual sales doubling, further solidifying the group's market position.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10